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Abstract: The objective of this study was to investigate the effect of tamsulosin (TAM) dosages on ejaculation and semen quality. Two
sets of Latin square experiment design were applied to 6 bucks receiving normal saline (CON), TAM 134.8 nM/kg (LTAM), or 269.7
(HTAM) nM/kg at 1-week intervals. Semen collection, libido, and ejaculatory scoring were undertaken at 3, 6, 9, 12, and 24 h after
injection. Heart rate and body temperature were measured before administration and at 30 min, and before semen collection. The results
showed that libido score and heart rate were not affected by treatments. Ejaculatory suppression was observed in both TAM groups.
The percentage of ejaculatory suppression was 91.7% by 3 h for both TAM dosages and gradually diminished. Ejaculatory recovery in
all bucks was observed by 12 h. Ejaculatory suppression remained unchanged between LTAM and HTAM, but HTAM caused more
anejaculation by 6 h (P < 0.05). Some semen parameters of both TAM groups were significantly different from the CON group from 6
to 12 h; however, the values returned to being similar by 24 h. Both TAM dosages had temporary effects on ejaculatory suppression and
semen quality, and the effective period was dose-dependent.
Key words: Alpha adrenoceptor antagonist, tamsulosin, buck, semen, ejaculation

1. Introduction
Temporary inhibition of ejaculation while sustaining
normal sexual behavior might be a useful tool in
controlling animal populations or heat detection in a herd.
Tamsulosin (TAM), an alpha adrenoceptor antagonist, has
been routinely used to treat benign prostatic hyperplasia in
humans and adversely suppresses ejaculation in men (1,2)
and bucks (3). This drug could also prove efficacious as a
temporary contraception choice in animals, but sufficient
information seems lacking in this field.
TAM, known as (-)-(R)-5-[2-[[2-(o-ethoxyphenoxy)
ethyl]amino]propyl]-2-methoxybenzenesulfonamide
monohydrochloride, has a high affinity for alpha-1
adrenoceptors in the human prostate gland and aorta (4–
6) and induces smooth muscle relaxation in the prostate,
bladder neck, and urethra. It was shown to decrease male
urogenital tract contractions in dogs (7) and rats (8).
Moreover, TAM adversely affects the expulsion phase
during ejaculation in rats (9) and markedly reduces semen
volume in men (1). Furthermore, an inhibitory effect on
* Correspondence: fvetacp@ku.ac.th

ejaculation while maintaining normal sexual desire was
reported in bucks (3).
Interestingly, varying alpha adrenoceptor antagonist
dosages affect sexual activity, as observed with alpha-2
adrenoceptor antagonists (such as yohimbine, rauwolscine,
and idazoxan). Low-dose yohimbine (2.0 µg/kg) may
stimulate sexual activity in rats, while a high dose (8.0 µg/
kg) suppressed the activity (10). Rauwolscine and idazoxan
also show dose-dependent effects on sexual response and
ejaculated semen volume (11). Low doses of rauwolscine
(0.1 and 0.3 mg/kg) markedly increased the ejaculated
semen volume; however, high doses (1.0 and 2.0 mg/kg)
decreased the ejaculated semen volume while markedly
inhibiting the penile erection and pelvic thrusting
behavior in dogs (11). TAM causes a dose-dependent
effect on suppression of the intraurethral pressure with
negligible effects on the arterial blood pressure effects in
dogs (12). However, the effect of various TAM dosages, for
example, on ejaculatory suppression and semen quality,
has not been investigated in bucks.
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Bucks have a distinctly high libido, making them a
suitable model for assessing the effects of various factors
(drugs) on sexual suppression. Therefore, the dose-related
effects of TAM on some reproductive parameters (libido,
ejaculation, and semen quality) were investigated herein
using a goat model.
2. Materials and methods
2.1. Animals and trials
The protocol was approved by the Animal Usage and Ethics
Committee of Kasetsart University (ID No. ACKU 02156).
Six cross-breed bucks (aged 1–3 years, weighing 27–65
kg) were evaluated. Animals were kept in a single pen and
separated from female goats. They were confirmed to have
a good libido, normal ejaculating ability (via an artificial
vagina, AV), and normal semen quality
This experiment was designed as a 3 × 3 Latin square.
Each buck was administered a single dose of 0.09%
NaCl (normal saline, CON), TAM 134.8 nM/kg (60 µg/
kg, LTAM), or TAM 269.7 nM/kg (120 µg/kg, HTAM)
intramuscularly at 1-week intervals (Table 1). Since this
protocol was performed twice, each treatment group
comprised 12 trials in total.
2.2. Solution preparation
TAM and dimethyl sulfoxide (DMSO, TAM solvent) were
purchased from Sigma-Aldrich (St. Louis, MO, USA).

TAM (50 mg) was dissolved in DMSO (1 mL) to generate
a concentrated stock solution, and then it was diluted
with additional DMSO (200 µL) prior to administration.
Normal saline (200 µL) was administered during the
control trial.
2.3. Libido scoring and semen collection
Semen was collected via an AV with a natural female in
estrus to trigger mating behavior at 3, 6, 9, 12, and 24 h
following drug administration. Libido was scored as
described by Frydrychova et al. (13) as shown in Table
2, but with some modification. Each buck had chances
to copulate once or twice within 10–20 min. In the first
attempt, if no semen was found in the AV collecting tube
after thrusting, the male with ejaculatory suppression was
allowed to have the second chance of mounting within 10
min.
2.4. Ejaculatory scoring
Ejaculation was classified into three groups: anejaculation,
incomplete ejaculation, and complete ejaculation.
Anejaculation was defined as the lack of semen in the
AV collecting tube. Incomplete ejaculation was defined
as a collected semen volume that included spermatozoa
but was less than 0.1 mL and complete ejaculation as
semen volume of at least 0.1 mL containing spermatozoa.
Ejaculation was scored as follows: 0 (anejaculation), 1
(incomplete ejaculation), or 2 (complete ejaculation).

Table 1. Sequence of soluble injection in each week and buck groups.
Buck group
(n)

Time points (weeks)
Week 1

Week 2

Week 3

Group 1 (n = 2)

CON

LTAM

HTAM

Group 2 (n = 2)

LTAM

HTAM

CON

Group 3 (n = 2)

HTAM

CON

LTAM

Table 2. Libido score characterization.
Score

Evaluation

Characterization of libido

0

No jumping

No thrusting or copulation, no sexual interest.

1

Inconvenient

Little sexual interest, prolonged thrusting and copulation, more than 10 min for ejaculation.

2

Substandard

Little sexual interest, several times following out jump, longer time to thrusting and copulation, duration
of face contact until ejaculation between 5 and 10 min.

3

Standard

Moderate sexual interest, using incentive to thrust and copulate, duration of face contact until ejaculation
between 3 and 5 min.

4

Very good

Great sexual interest, longer searching reflex with consecutive copulation, duration of face contact until
ejaculation between 1 and 3 min.

5

Excellent

Intense sexual interest, copulation immediately after face contact, duration of jump until ejaculation
within 1 min.
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2.5. Semen quality assessment
The semen volume, mass spermatozoal movement score,
percentages of motile and live spermatozoa, spermatozoal
concentration, total spermatozoa per ejaculate, and
seminal alkaline phosphatase (ALP) concentration were
measured to assess the semen quality.
Semen volume was measured using automatic pipettes.
Mass spermatozoal movement was scored from 0 (immotile)
to 5 (high), and the percentage of motile spermatozoa was
measured immediately following collection using light
microscopy. Spermatozoal concentration was estimated by
hemocytometer. The percentage of live spermatozoa was
based on the hypoosmotic swelling test (14). Seminal ALP
was analyzed using the Reflotron dry chemistry method
(Roche, Mannheim, Germany).
2.6. Heart rate and temperature measurement
Heart rate and body temperature were measured at 30
min before drug administration and before each semen
collection.
2.7. Statistical analyses
The data from semen volume, percentages of motile and
live sperm, sperm concentration, total sperm, ALP, heart
rate, and body temperature were analyzed using analysis of
variance for Latin square experimental designs using SPSS
17. Libido score, ejaculation score, number of ejaculatory
characteristics, and mass spermatozoal movement score
were examined by chi-square test. Mean values were
considered statistically significantly different at P < 0.05.
All values except the number of ejaculations are shown as
the mean and standard error of the mean (mean ± SEM).
3. Results
3.1. Effect on libido
All bucks responded to the female goats. The mean libido
score did not show any statistical difference (P > 0.05)
between treatment groups and time periods (Table 3). In
the first week, the ejaculated semen was missed during
collection in one buck receiving normal saline (3 h);
however, his libido score was included in the analyses.

3.2. Effect on ejaculation
In the CON group, complete ejaculation was achieved in
all cases. Both anejaculation and incomplete ejaculation
were observed in the LTAM and HTAM groups at 3 to 9
h after injection (Table 4). The distribution of ejaculatory
suppression types was similar (P > 0.05) between the LTAM
and HTAM treatments at each time period. At 3 h after
injection, anejaculation was comparable following LTAM
and HTAM at 33.3% and 50%, respectively. However, at
6 h after injection, a significantly higher (P < 0.05) rate
of anejaculation was observed following HTAM than
after LTAM and CON (50%, 0%, and 0%, respectively). In
addition, incomplete ejaculation occurred in significantly
(P < 0.05) more occasions following LTAM than following
CON. The ejaculatory scores following LTAM and HTAM
were significantly lower (P < 0.05) than that of CON at
3 h after injection, and the score remained significantly
lower following HTAM through 6 h after injection. The
ejaculatory suppression and ejaculatory scores were
similar (P > 0.05) between the groups at 9 h after injection.
3.3. Effect on semen quality
Considering the lack of data for the CON group, a
comparative analysis between the groups was not
performed. Collected semen volume following incomplete
and complete ejaculation in all groups is summarized in
Table 5. The semen volume for incomplete ejaculation
showed no significant difference (P > 0.05) between the
LTAM and HTAM groups. However, the semen volume for
complete ejaculation was quite similar between the groups
at all periods except those of 12 h after injection, which
had a significantly higher volume in the LTAM group than
in the CON group (P < 0.05).
The remaining comparisons of semen quality
comparisons following the complete ejaculation are
summarized in Table 6. Seminal ALP concentrations
were similar between the groups at all periods. However,
the percentage of sperm motility was significantly lower
in the HTAM group than those in the CON and LTAM
groups at 6 h (P < 0.05). The percentage of live sperm
was significantly lower in the HTAM group than those in
the CON at 9 h (P < 0.05). The sperm concentration and

Table 3. Libido scores between 3 and 24 h after injection of normal saline (CON), tamsulosin 134.8 nM/kg (LTAM), and tamsulosin
269.7 nM/kg (HTAM) (mean ± SEM).

Group

n

CON

Libido score (per hour, h)
3h

6h

9h

12 h

24 h

12

5.0

5.0

4.9 ± 0.1

4.9 ± 0.1

5.0

LTAM

12

5.0

4.9 ± 0.1

4.9 ± 0.1

4.9 ± 0.1

4.9 ± 0.1

HTAM

12

5.0

5.0

5.0

4.8 ± 0.1

4.9 ± 0.1
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Table 4. Numbers of anejaculation, incomplete ejaculation, and complete ejaculation at 3–24 h after injection of normal saline (CON),
tamsulosin 134.8 nM/kg (LTAM), and tamsulosin 269.7 nM/kg (HTAM).
Ejaculatory suppression**

Hour
(h)

Group

n

Complete
ejaculation (%)

Incomplete ejaculation (%)

Anejaculation (%)

Total (%)

Ejaculatory
score

3h

CON

11*

11b (100)

0a (0)

0a (0)

0a (0)

22b

LTAM

12

1a (8.3)

7b (58.3)

4b (33.3)

11b (91.7)

9a

HTAM

12

1a (8.3)

5b (41.7)

6b (50)

11b (91.7)

7a

CON

12

12b (100)

0a (0)

0a (0)

0a (0)

24b

LTAM

12

6 (50)

6 (50)

0 (0)

6 (50)

18ab

HTAM

12

4a (33.3)

2ab (16.7)

6b (50)

8b (66.7)

10a

6h

9h

12 h

24 h

a

b

a

b

CON

12

12 (100)

0 (0)

0 (0)

0 (0)

24

LTAM

12

11 (91.7)

1 (8.3)

0 (0)

1 (8.3)

23

HTAM

12

9 (75)

3 (25)

0 (0)

3 (25)

21

CON

12

12 (100)

0 (0)

0 (0)

0 (0)

24

LTAM

12

12 (100)

0 (0)

0 (0)

0 (0)

24

HTAM

12

12 (100)

0 (0)

0 (0)

0 (0)

24

CON

12

12 (100)

0 (0)

0 (0)

0 (0)

24

LTAM

12

12 (100)

0 (0)

0 (0)

0 (0)

24

HTAM

12

12 (100)

0 (0)

0 (0)

0 (0)

24

*One buck in this treatment missed collection.
**Ejaculatory suppression = incomplete ejaculation + anejaculation.
ab
Means having different superscripts at the same time points are significantly different at P < 0.05.
Table 5. Collectable semen volumes between 3 and 24 h after injection of normal saline (CON), tamsulosin
134.8 nM/kg (LTAM), and tamsulosin 269.7 nM/kg (HTAM) (mean ± SEM).
Hour
(h)
3h

6h

9h

12

24 h

Group

n

Semen volume (mL)
Complete ejaculation (n)

Incomplete ejaculation (n)

CON

11

0.517 ± 0.06 (11)

-

LTAM

8

0.262 (1)

0.014 ± 0.004 (7)

HTAM

6

0.17 (1)

0.018 ± 0.008 (5)

CON

12

0.401 ± 0.06 (12)

-

LTAM

12

0.419 ± 0.106 (6)

0.029 ± 0.012 (6)

HTAM

6

0.381 ± 0.128 (4)

0.015 ± 0.010 (2)

CON

12

0.456 ± 0.06 (12)

-

LTAM

12

0.641 ± 0.075 (11)

0.01 (1)
0.07 ± 0.001 (3)

HTAM

12

0.637 ± 0.131 (9)

CON

12

0.381 ± 0.03a (12)

-

LTAM

12

0.706 ± 0.09b (12)

-

HTAM

12

0.574 ± 0.08ab (12)

-

CON

12

0.465 ± 0.08 (12)

-

LTAM

12

0.582 ± 0.07 (12)

-

HTAM

12

0.559 ± 0.06 (12)

-

Means having different superscripts at the same time points are significantly different at P < 0.05.

ab
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Table 6. Semen quality following complete ejaculations between 3 and 24 h after injection of normal saline (CON), tamsulosin 134.8
nM/kg (LTAM), and tamsulosin 269.7 nM/kg (HTAM) (mean ± SEM).
Hour
(h)

Group

n

Sperm
motility
(%)

Mass sperm
movement
score

Sperm
concentration
(×109 cells/mL)

Total sperm
(×109 cells)

Live
sperm (%)

ALP
(×104 IU)

3h

CON

11

87.3 ± 2.4

4.8 ± 0.1

4.1 ± 0.5

12.2 ± 1.3

34.8 ± 6.2

8.1 ± 1.8

LTAM

1

95

5.0

5.6

16.9

27.5

11.1

HTAM

1

50

3.0

2.4

7.1

9.5

2.4

CON

12

80 ± 3.1

4.8 ± 0.1

3.9 ± 0.6

11.8 ± 1.9

36 ± 5.6

8.4 ± 2.2

LTAM

6

75.0 ± 5.5b

4.5 ± 0.3

5.2 ± 1.4

15.5 ± 4.1

32.4 ± 7.4

17.8 ± 7.8

HTAM

4

57.5 ± 9.5

3.8 ± 0.8

4.9 ± 0.9

14.8 ± 2.6

27.5 ± 14.0

8.7 ± 1.9

CON

12

73.8 ± 8.3

4.3 ± 0.4

3.2 ± 0.4

9.7 ± 1.2

36.1 ± 4.5b

5.4 ± 0.6

LTAM

11

73.2 ± 3.8

4.3 ± 0.4

4.8 ± 0.8

14.4 ± 2.4

28.5 ± 3.4

10.0 ± 3.1

HTAM

9

76.7 ± 5.3

4.0 ± 0.4

4.2 ± 0.7

12.5 ± 2.2

18.8 ± 3.1a

6.0 ± 0.8

CON

12

75.8 ± 4.7

4.4 ± 0.3

3.0 ± 0.2

8.8 ± 0.6

37.8 ± 3.0

4.2 ± 0.5

LTAM

12

57.5 ± 6.5

3.6 ± 0.4

4.2 ± 0.3b

12.6 ± 1.0b

31 ± 4.4

6.0 ± 0.9

HTAM

12

57.9 ± 8.3

3.3 ± 0.4

4.6 ± 0.3

13.8 ± 0.9

27.9 ± 5.1

5.7 ± 0.8

CON

12

60.0 ± 7.3

3.7 ± 0.4

3.2 ± 0.3

9.6 ± 1.0

37.2 ± 4.7

4.3 ± 0.6

LTAM

12

65.8 ± 5.9

3.6 ± 0.5

4.1 ± 0.3

12.2 ± 0.8

35.8 ± 3.0

4.5 ± 0.6

HTAM

12

62.5 ± 6.0

3.1 ± 0.4

4.2 ± 0.6

12.5 ± 1.7

31.8 ± 4.6

5.3 ± 0.6

6h

9h

12 h

24 h

b

a

a

b

a

b

ab

Means having different superscripts at the same time points are significantly different at P < 0.05.

ab

total sperm measurements were significantly higher in the
HTAM and LTAM groups than in the CON group at 12
h (P < 0.05). At 24 h after injection, none of the semen
quality parameters between the groups had significant
differences (P > 0.05).
3.4. Heart rate and temperature
The heart rate and body temperature were similar (P >
0.05) between the groups in all periods (Table 7).
4. Discussion
This study demonstrated clearly that both TAM dosages
used (134.8 and 269.7 nM/kg) temporarily suppressed
ejaculation in the buck with no side-effects on libido
or body physiology (heart rate and body temperature).
Moreover, TAM-induced suppression, particularly
anejaculation, was dose-dependent.
Maintaining the dominant male’s sexual behavior, as a
temporary contraception, could prevent repeated mating
by subordinate males. In this study, neither TAM dose
affected the buck’s libido, as similarly observed in our
previous study using a 179.8 nM/kg (80 µg/kg) TAM dose

(3). A potential dose-dependent effect on libido, similar to
other alpha adrenoceptor antagonists (such as yohimbine,
causing variable sexual activity in rats in a dose-dependent
manner (10)), was a concern. However, the libido scores
were similar in the LTAM and HTAM groups, which might
indicate either that the selected dosages were incapable of
producing an observable difference or that TAM had no
dose-dependent effect on libido. Both TAM dosages used
here (134.8 and 269.7 nM/kg) maintained the dominant
buck’s libido (i.e. the ability and desire to engage in normal
copulation).
Both LTAM and HTAM dosages induced the greatest
ejaculatory suppression (incomplete ejaculation and
anejaculation) by 3 h after injection; thereafter, the effect
gradually decreased until complete recovery by 12 h.
Although ejaculatory suppression occurred at similar rates
between the TAM groups, the number of anejaculation
events was higher in the HTAM group than in the LTAM
group by 6 h after injection. This indicates that the high
TAM concentration was associated with greater ejaculatory
suppression than the low TAM concentration. Increased
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Table 7. Changes of heart rate and body temperature between 0 and 24 h after injection
of normal saline (CON), tamsulosin 134.8 nM/kg (LTAM), and tamsulosin 269.7 nM/
kg (HTAM) (mean ± SEM).
Hour (h)

Group

Heart rate (bpm)

Temperature (°C)

0h

CON

64.5 ± 4.5

38.72 ± 0.3

LTAM

69.0 ± 3.3

38.67 ± 0.2

HTAM

60.7 ± 5.8

38.61 ± 0.2

CON

80.0 ± 5.5

38.72 ± 0.3

LTAM

85.0 ± 6.2

38.33 ± 0.3

HTAM

89.2 ± 4.2

38.33 ± 0.3

CON

81.8 ± 6.1

39.11 ± 0.3

LTAM

87.5 ± 3.2

39.00 ± 0.2

HTAM

82.0 ± 4.8

39.00 ± 0.3

CON

85.0 ± 4.4

39.17 ± 0.2

LTAM

86.5 ± 3.6

39.11 ± 0.2

HTAM

86.8 ± 5.3

39.28 ± 0.2

CON

84.5 ± 4.9

39.28 ± 0.3

LTAM

84.0 ± 3.5

39.06 ± 0.2

HTAM

79.5 ± 5.0

39.22 ± 0.2

CON

74.8 ± 4.1

38.94 ± 0.4

LTAM

70.8 ± 3.1

38.67 ± 0.2

HTAM

73.5 ± 2.5

38.94 ± 0.1

3h

6h

9h

12 h

24 h

intraurethral pressure in dogs (12) and salivary inhibition in
rats (15) were both reported to occur in a dose-dependent
manner with alpha-1 adrenoceptor antagonist. The dosedependent effect of TAM on ejaculation demonstrated
herein may indicate the involvement of the central nervous
system. The possible sequence of TAM-induced ejaculatory
suppression has been proposed previously (9,16). TAM
may suppress ejaculation through its powerful affinity for
5-hydroxytryptamine 1A and dopamine 2-like receptors
that are involved in the main regulation of ejaculation
(9,16). This binding may lead to: 1) relaxation of urethral
smooth muscles (7,17), 2) decrease of seminal vesicle
pressure (8), and 3) reduction of the bulbospongiosus
muscle contraction (9), collectively resulting in ejaculatory
suppression in a dose-dependent manner.
Interestingly, once the TAM effect dissipated, the
semen volume for complete ejaculation in the LTAM
group was markedly higher than that in the CON group
by 12 h after injection. An increased semen volume has
not been previously reported for alpha-1 adrenoceptor
antagonists. However, an elevated postejaculatory semen
volume has been reported in dogs receiving low doses of
alpha-2 adrenoceptor antagonists, such as rauwolscine and
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idazoxan (11), and the effect might also occur in animals
receiving TAM. Alternatively, the repeated ejaculation
events in bucks receiving normal saline might have
caused a consistent or reduced semen volume (18,19), and
therefore the importance of this remains unclear. Notably,
by 24 h after injection, the semen volume remained similar
between the groups.
The elevated semen volume may also explain the
higher sperm concentration and total sperm in the LTAM
and HTAM groups than in the CON group by 12 h after
injection. As was the case with semen volume, both the
sperm concentration and total sperm were similar between
the groups by 24 h after injection.
The sperm motility at 6 h and live sperm percentages
at 9 h were markedly lower in the HTAM group than in
the CON or LTAM groups. This trend is consistent with
our previous study, using 179.8 nM/kg TAM (3). TAM
presumably alters the epididymal epithelial secretory
and absorptive functions, or epididymal contraction,
ultimately impairing spermatozoa viability as proposed
by Kimsakulvech et al. (3). This effect was also dosedependent, similar to previous reports investigating the
salivary gland function (15).

KIMSAKULVECH et al. / Turk J Vet Anim Sci

Alterations in seminal ALP concentration may
indicate epididymal blockage (20), but the concentrations
used herein did not differ between groups. Potentially,
TAM might inhibit all the reproductive tract’s smooth
muscle contraction. Heart rate and body temperature
values remained unchanged and were similar between the
groups over time, presumably indicating that the selected
TAM dosages did not adversely affect cardiovascular and
metabolic function in bucks.
In conclusion, the present study showed that TAM
administered at 134.8 and 269.7 nM/kg dosages has
temporary suppressive effects on ejaculation in bucks from
3 h to 9 h and led to altered semen quality up to 12 h after
injection, both in a dose-dependent fashion. Moreover, the

TAM effect was negligible at 24 h after injection. TAM did
not affect the libido, allowing the male to remain actively
dominant. Therefore, it was considered that TAM could be
utilized as a temporary contraception of choice in males;
nevertheless, further confirmation with future studies is
warranted in animals of different species.
Acknowledgments
This study was supported by the Centre for Agricultural
Biotechnology, Kasetsart University, and the Centre of
Excellence on Agricultural Biotechnology, Postgraduate
Education and Research Development Office, Commission
on Higher Education, Ministry of Education (AG-BIO/
PERDO-CHE).

References
1.

Hellstrom WJG, Sikka SC. Effects of acute treatment with
tamsulosin versus alfuzosin on ejaculatory function in normal
volunteers. J Urol 2006; 176: 1529–1533.

2.

Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto
T. Ejaculatory disorder caused by alpha-1 adrenoceptor
antagonists is not retrograde ejaculation but a loss of seminal
emission. Int J Urol 2006; 13: 1311–1316.

3.

Kimsakulvech S, Suttiyotin P, Pinyopummin A. Effects of
alpha1-adrenoceptor antagonist (tamsulosin) on incident of
ejaculation and semen quality in the goat. Andrologia 2015; 47:
354–359.

4.

Foglar R, Shibata K, Horie K, Hirasawa A, Tsujimoto G. Use
of recombinant alpha 1-adrenoceptors to characterize subtype
selectivity of drugs for the treatment of prostatic hypertrophy.
Eur J Pharmacol 1995; 288: 201–207.

5.

Taguchi K, Saitoh M, Sato S, Asano M, Michel MC. Effects of
tamsulosin metabolites at alpha-1 adrenoceptor subtypes. J
Pharmacol Exp Ther 1997; 280: 1–5.

6.

Yamada S, Suzuki M, Tanaka C, Mori R, Kimura R, Inagaki O,
Honda K, Asano M, Takenaka T, Kawabe K. Comparative study
on alpha1 adrenoceptor antagonist binding in human prostate
and aorta. Clin Exp Pharmacol Physiol 1994; 21: 405–411.

7.

Kobayashi S, Tomiyama Y, Tatemichi S, Hoyano Y, Kobayashi M,
Yamazaki Y. Effects of silodosin and tamsulosin on the urethra
and cardiovascular system in young and old dogs with benign
prostatic hyperplasia. Eur J Pharmacol 2009; 613: 135–140.

8.

Giuliano F, Bernabe J, Droupy S, Alexandre L, Allard J. A
comparison of the effects of tamsulosin and alfuzosin on
neurally evoked increases in bladder neck and seminal vesicle
pressure in rats. BJU Int 2004; 93: 605–608.

9.

Giuliano FA, Clement P, Denys P, Alexandre L, Bernabe J.
Comparison between tamsulosin and alfuzosin on the expulsion
phase of ejaculation in rats. BJU Int 2006; 98: 876–879.

10.

Smith ER, Lee RL, Schnur SL, Davidson JM. Alpha2
adrenoceptor antagonists and male sexual behavior: I. Mating
behavior. Physiol Behav 1987; 41: 7–14.

11.

Yonezawa A, Ando R, Watanabe C, Furuta S, Kutsuwa M,
Sakurada S, Kimura Y. Alpha2 adrenoceptor antagonists: effects
on ejaculation, penile erection and pelvic thrusting behavior in
dogs. Pharmacol Biochem Behav 2001; 70: 141–147.

12.

Ohtake A, Sato S, Saitoh C, Yuyama H, Sasamata M, Miyata K.
Effects of tamsulosin on hypogastric nerve stimulation-induced
intraurethral pressure elevation in male and female dogs under
anesthesia. Eur J Pharmacol 2004; 497: 327–334.

13.

Frydrychova S, Opletal L, Macakova K, Lustykova A, Rozkot M,
Lipensky J. Effects of herbal preparation on libido and semen
quality in boars. Reprod Domest Anim 2011; 46: 573–578.

14.

Revell SG, Mrode RA. An osmotic resistance test for bovine
semen. Anim Reprod Sci 1994; 36: 77–86.

15.

Yanai-Inamura H, Ohtake A, Noguchi Y, Hatanaka T, Suzuki M,
Ueshima K, Sato S, Sasamata M. Effects of alpha1 adrenoceptor
antagonists on phenylephrine-induced salivary secretion and
intraurethral pressure elevation in anesthetized rats. Eur J
Pharmacol 2012; 679: 127–131.

16.

Andersson KE, Wyllie MG. Ejaculatory dysfunction: why all
alpha-blockers are not equal. BJU Int 2003; 92: 876–877.

17.

Ohtake A, Ukai M, Saitoh C, Sonoda R, Noguchi Y, Okutsu H,
Yuyama H, Sato S, Sasamata M, Miyata K. Effect of tamsulosin on
spontaneous bladder contraction in conscious rats with bladder
outlet obstruction: comparison with effect on intraurethral
pressure. Eur J Pharmacol 2006; 545: 185–191.

18.

Kaya A, Aksoy M, Tekeli T. Influence of ejaculation frequency
on sperm characteristics, ionic composition and enzymatic
activity of seminal plasma in rams. Small Rumin Res 2002; 44:
153–158.

19.

Ritar AJ, Mendoza G, Salamon S, White IG. Frequent semen
collection and sperm reserves of the male Angora goat (Capra
hircus). J Reprod Fertil 1992; 95: 97–102.

20.

Joni LF. Semen collection and evaluation. Clin Tech Small Anim
Pract 2002; 17: 104–107.

471

